Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration
The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) were developed to address widespread deficiencies in the reporting of such studies. The REMARK checklist consists of 20 items to report for published tumor marker prognostic studies. A detailed paper was published explaining...
| Principais autores: | , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
Oxford University Press
2018
|
| _version_ | 1826288111099838464 |
|---|---|
| author | Sauerbrei, W Taube, SE McShane, LM Cavenagh, MM Altman, DG |
| author_facet | Sauerbrei, W Taube, SE McShane, LM Cavenagh, MM Altman, DG |
| author_sort | Sauerbrei, W |
| collection | OXFORD |
| description | The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) were developed to address widespread deficiencies in the reporting of such studies. The REMARK checklist consists of 20 items to report for published tumor marker prognostic studies. A detailed paper was published explaining the rationale behind checklist items, providing positive examples and giving empirical evidence of the quality of reporting. REMARK provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general. Despite support for REMARK from major cancer journals, prognostic factor research studies remain poorly reported. To encourage dissemination and uptake of REMARK, we have produced this considerably abridged version of the detailed explanatory manuscript, which may also serve as a brief guide to key issues for investigators planning tumor marker prognostic studies. To summarize the current situation, more recent papers investigating the quality of reporting and related reporting guidelines are cited, but otherwise the literature is not updated. Another important impetus for this paper is that it serves as a basis for literal translations into other languages. Translations will help to bring key information to a larger audience world-wide. Many more details can be found in the original paper. |
| first_indexed | 2024-03-07T02:08:47Z |
| format | Journal article |
| id | oxford-uuid:9fe22ebc-f7bc-4de3-a260-df17915b88b5 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:08:47Z |
| publishDate | 2018 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:9fe22ebc-f7bc-4de3-a260-df17915b88b52022-03-27T02:01:29ZReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaborationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9fe22ebc-f7bc-4de3-a260-df17915b88b5EnglishSymplectic Elements at OxfordOxford University Press2018Sauerbrei, WTaube, SEMcShane, LMCavenagh, MMAltman, DGThe Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) were developed to address widespread deficiencies in the reporting of such studies. The REMARK checklist consists of 20 items to report for published tumor marker prognostic studies. A detailed paper was published explaining the rationale behind checklist items, providing positive examples and giving empirical evidence of the quality of reporting. REMARK provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general. Despite support for REMARK from major cancer journals, prognostic factor research studies remain poorly reported. To encourage dissemination and uptake of REMARK, we have produced this considerably abridged version of the detailed explanatory manuscript, which may also serve as a brief guide to key issues for investigators planning tumor marker prognostic studies. To summarize the current situation, more recent papers investigating the quality of reporting and related reporting guidelines are cited, but otherwise the literature is not updated. Another important impetus for this paper is that it serves as a basis for literal translations into other languages. Translations will help to bring key information to a larger audience world-wide. Many more details can be found in the original paper. |
| spellingShingle | Sauerbrei, W Taube, SE McShane, LM Cavenagh, MM Altman, DG Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration |
| title | Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration |
| title_full | Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration |
| title_fullStr | Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration |
| title_full_unstemmed | Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration |
| title_short | Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration |
| title_sort | reporting recommendations for tumor marker prognostic studies remark an abridged explanation and elaboration |
| work_keys_str_mv | AT sauerbreiw reportingrecommendationsfortumormarkerprognosticstudiesremarkanabridgedexplanationandelaboration AT taubese reportingrecommendationsfortumormarkerprognosticstudiesremarkanabridgedexplanationandelaboration AT mcshanelm reportingrecommendationsfortumormarkerprognosticstudiesremarkanabridgedexplanationandelaboration AT cavenaghmm reportingrecommendationsfortumormarkerprognosticstudiesremarkanabridgedexplanationandelaboration AT altmandg reportingrecommendationsfortumormarkerprognosticstudiesremarkanabridgedexplanationandelaboration |